Telehealth Support for Type 1 Diabetes Management

Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

Recruiting N/A Interventional Study
Diabetes Mellitus, Type 1
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 18
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
82 (estimated)
Sponsor
University of California, Davis · Other
Who this trial is looking for

This trial is looking for kids and teens aged 5-18 who have type 1 diabetes that isn't well controlled. Participants will join virtual video visits and remote monitoring to help manage their diabetes over six months.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 5 and 18 years old
  • I have type 1 diabetes diagnosed for more than 12 months
  • I have high blood sugar levels at the time of enrollment
  • I plan to receive care at the UCD Pediatric Diabetes Clinic for the next year
  • I have internet access via a device with video and audio capability
  • I can connect my blood glucose meter or CGM to an internet device

You may not be able to join if

  • I live outside of California
  • I do not have access to a device that can connect to the internet
  • I cannot connect my glucose meter or CGM to a device

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This study will test the hypothesis that supplemental synchronous video visits and supplemental asynchronous remote monitoring can each significantly improve glycemic control for pediatric patients with uncontrolled type 1 diabetes over a 6 month period, and will compare health outcomes and patient-centered outcomes between these two intervention arms and a control arm receiving usual care.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. age 5-18 years 2. diagnosis of type 1 diabetes with a duration of \>12 months 3. suboptimal glycemic control at time of enrollment, defined as a hemoglobin A1c (HbA1c) level \> 8% (64 mmol/mol) or a 14-day glucose management index (GMI) of \>8% from continuous glucose monitor…
Contacts

No contact information available.